Similar articles

• CHA₂DS₂VASc Score and Coronary No-Reflow Phenomenon.

  Yarlioglues M, Yalcinkaya D, Celik IE, Duran M. Yarlioglues M, et al. Angiology. 2020 Feb;71(2):191. doi: 10.1177/0003319719851698. Epub 2019 May 23. Angiology. 2020. PMID: 31122028 No abstract available.
• Is it Time to Abandon Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation on Anticoagulation?

  Giri J, Nathan A. Giri J, et al. JACC Cardiovasc Interv. 2018 Apr 9;11(7):635-637. doi: 10.1016/j.jcin.2017.12.002. Epub 2018 Mar 14. JACC Cardiovasc Interv. 2018. PMID: 29550087 No abstract available.
• Oral anticoagulants for atrial fibrillation and acute coronary syndrome with or without stenting.

  Muscente F, Tautermann G, De Caterina R. Muscente F, et al. J Cardiovasc Med (Hagerstown). 2018 Feb;19 Suppl 1:e40-e45. doi: 10.2459/JCM.0000000000000597. J Cardiovasc Med (Hagerstown). 2018. PMID: 29538143 Review. No abstract available.
• New-onset atrial fibrillation after percutaneous coronary intervention with stent: Updated proposal of an algorithm for the choice of oral anticoagulant and its dose.

  Rubboli A, Agewall S, Huber K, Lip GYH. Rubboli A, et al. Eur J Intern Med. 2017 May;40:e11-e12. doi: 10.1016/j.ejim.2017.01.003. Epub 2017 Jan 10. Eur J Intern Med. 2017. PMID: 28087220 No abstract available.
• Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2016 Update.

  Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay JF, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP. Angiolillo DJ, et al. Circ Cardiovasc Interv. 2016 Nov;9(11):e004395. doi: 10.1161/CIRCINTERVENTIONS.116.004395. Circ Cardiovasc Interv. 2016. PMID: 27803042 Review.